News | July 06, 2024
Nephro Care India lists at 90% premium
NCIL was listed at Rs. 171 at an upper circuit premium of 90% over the fixed price band of Rs. 90
NCIL was listed at Rs. 171 at an upper circuit premium of 90% over the fixed price band of Rs. 90
Partners with Yifan Pharmaceutical to launch Synovian injection for osteoarthritis in China
Innovative technologies and comprehensive services to strengthen Syntegon’s strategic growth
Facility in The Woodlands, Texas to produce critical starting material for cell and gene therapy, DNA/RNA-based, and recombinant protein therapeutics in Q1/2025
Largest investment in active pharmaceutical ingredient manufacturing of synthetic medicines in U.S. history
The acquisition is immediately accretive and creates a compelling, single-stop, multi-continent partner for biopharma companies
Acquisition will advance Merck’s integrated offering for viral vector manufacturing
Cresset’s new India site will support the growing demands of Cresset’s APAC customer base
The joint venture will help JV Partners combine their strengths and grow their complementary nutraceuticals portfolios
Pemetrexed Injection is used as a drug, in the treatment of non-small cell lung cancer in combination with other chemotherapy agents
Subscribe To Our Newsletter & Stay Updated
